Skip to content

Clinical trials

Completed Phase 1 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 1 Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20061
20072
20097
20104
20111
20124
20131
20163
20171
20182
20201
20214
20222
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Syndax Pharmaceuticals3
Aeris Therapeutics2
AstraZeneca2
Global Alliance for TB Drug Development2
Guangzhou JOYO Pharma Co., Ltd2
Michael Hoelscher2
NYU Langone Health2
Pfizer2
Pulmatrix Inc.2
AO GENERIUM1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases42
Respiratory Tract Diseases11
Neoplasms8
Lung Neoplasms7
Pulmonary Disease, Chronic Obstructive7
Carcinoma, Non-Small-Cell Lung6
Respiratory Tract Neoplasms5
Thoracic Neoplasms5
Bronchial Neoplasms4
Idiopathic Pulmonary Fibrosis4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.